Fujisawa Pharmaceutical Co., Ltd. Chooses Sprint to Connect Operations in Asia, Europe and North America

07.04.2004

Overland Park and TOKYO. Sprint announced that it has installed an IP VPN (Internet Protocol Virtual Private Network) for Fujisawa, a Japan-based pharmaceutical company with operations throughout Asia, Europe and North America. Through a two-year agreement, Sprint will connect Fujisawa offices in Japan, China, Taiwan, Korea, Ireland, Germany, the United Kingdom, France, Switzerland, Netherlands, Sweden, Belgium, Italy, Spain and the United States. "We wanted our network to mirror our corporate strategy, which aims to accelerate the speed of globalization," said Hiro Atsumaru, IT manager at Fujisawa. "With Sprint, we are able to increase nearly three to four times our network speed at no additional cost. We view this secure VPN solution as a critical tool to gain operational efficiency and grow our business." "The global network development was the result of great collaboration among Fujisawa's Japan headquarters, Fujisawa's IT/IS departments in Germany and the United States as well as the Sprint network engineers," said Masahiko Sejima, director of IT Infrastructure Solution at Fujisawa System Technology Inc. "The plan was smoothly implemented because of the close and timely communication between all parties." Sprint's IP VPN solutions can enable companies to communicate securely and cost effectively with employees, customers, business partners and suppliers. They provide the access required for establishing enterprise-wide intranets, extranets and remote access in addition to secure, encrypted connections necessary for transporting sensitive data across the Internet. "Sprint's IP VPN solution, using Cisco Systems equipment, provides the security and flexibility that a global business like Fujisawa demands," said Kei Furuta, Sprint's managing director for Japan and Korea. "In addition, it's backed by Sprint's industry-leading service level agreements which provide businesses predictable, high levels of service across their networks."

https://www.bionity.com/de/news/36601/fujisawa-pharmaceutical-co-ltd-chooses-sprint-to-connect-operations-in-asia-europe-and-north-america.html